CD274 and squamous cell carcinoma: Studies have indicated that compared to non-squamous cell carcinoma, lung squamous cell carcinoma exhibits higher PD-L1 expression, higher tumor mutational burden (TMB), and a greater density of functional TILs in the tumor microenvironment, factors that collectively contribute to the enhanced therapeutic effects of immunotherapy in squamous cell carcinoma patients (28).